Anhui Wanbang Pharmaceutical Technology Co.,Ltd. — Investor Relations & Filings

Anhui Wanbang Pharmaceutical Technology Co., Ltd. is a comprehensive pharmaceutical research and development service provider specializing in clinical research and technical services. Operating primarily as a Contract Research Organization (CRO), the company offers a wide range of services including bioequivalence (BE) studies, Phase I through IV clinical trials, and pharmacokinetics (PK/PD) research. It provides end-to-end solutions for pharmaceutical development, encompassing clinical trial design, site management, data management, and statistical analysis. The firm focuses on supporting generic drug consistency evaluations and the development of innovative drugs. By maintaining advanced laboratory facilities and clinical research centers, the company ensures compliance with international quality standards and regulatory requirements to facilitate the market entry of diverse therapeutic products.